|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Patient accounts receivable, less provision for credit losses of $3,824 and $3,775, respectively | ||||||||||||||||||||
| Accounts receivable - other | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets: | ||||||||||||||||||||
| Furniture and equipment | ||||||||||||||||||||
| Leasehold improvements | ||||||||||||||||||||
| Fixed assets, gross | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Investment in unconsolidated affiliate | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other identifiable intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTEREST | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable - trade | ||||||||||||||||||||
| Accounts payable - due to seller of acquired business | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Current portion of term loan and notes payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable, net of current portion | ||||||||||||||||||||
| Revolving facility | ||||||||||||||||||||
| Term loan, net of current portion and deferred financing costs | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Operating lease liabilities, net of current portion | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable non-controlling interest - temporary equity | ||||||||||||||||||||
| U.S. Physical Therapy, Inc. ("USPH") shareholders' equity: | ||||||||||||||||||||
| Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding | ||||||||||||||||||||
| Common stock, $.01 par value, 20,000,000 shares authorized, 17,526,791 and 17,418,621 shares issued, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive gain | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock at cost, 2,603,117 shares and 2,296,059 shares, respectively | ||||||||||||||||||||
| Total USPH shareholders' equity | ||||||||||||||||||||
| Non-controlling interest - permanent equity | ||||||||||||||||||||
| Total USPH shareholders' equity and non-controlling interest - permanent equity | ||||||||||||||||||||
| Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity |
Loading...
